A clinical trial enrolling patients in Shreveport could potentially help women struggling with peripartum cardiomyopathy, the leading cause of death in pregnant women.
Bromocriptine, a medication currently being used in a clinical study at LSU Health Shreveport is used to treat multiple conditions, including Parkinson’s disease.
According to Dr. Kalgi Modi, Professor of Internal Medicine and Interim Division Chief of Cardiology at LSU Health Shreveport, it may also help women struggling with peripartum cardiomyopathy, a weakened heart condition that develops after childbirth…